GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » Net Interest Income (for Banks)

Centessa Pharmaceuticals (STU:260) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Centessa Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.